Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;56(7):1119-1130.
doi: 10.1111/apt.17165. Epub 2022 Aug 21.

Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses

Mengshi Yi  1 , Wei Peng  1 , Xi Feng  1 , Fei Teng  1 , Youyin Tang  2 , Qingyan Kong  1 , Zheyu Chen  1
Affiliations

Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses

Mengshi Yi et al. Aliment Pharmacol Ther. 2022 Oct.

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) has reached pandemic proportions currently and may contribute to multiple extrahepatic outcomes.

Aim: To comprehensively summarise evidence of associations between NAFLD and risk of extrahepatic outcomes.

Methods: We conducted an umbrella review. We searched PubMed, Web of Science and Cochrane database from inception to 27 November 2021.

Results: We included 22 meta-analyses with 374 original studies in our analysis. Subjects with NAFLD had an increased risk of mortality, multiple cardiovascular complications, extrahepatic cancers, diabetes and chronic kidney disease (CKD) than those without NAFLD. Excess risks of several other extrahepatic outcomes including hypothyroidism, urolithiasis, gastro-oesophageal reflux disease, gallstones, depression and worse maternal and foetal outcomes were also observed in this population. However, associations were not significant for prostate cancer, female organ genital cancer, haematological cancer, diabetic retinopathy or osteoporotic fracture. The risks of CVD, diabetes and CKD were similar in obese and non-obese patients. Most associations were heterogeneous across regions; significantly, Europeans with NAFLD were more prone to all-cause mortality than North Americans. The certainty of evidence was graded from only very low to moderate as all included studies were observational.

Conclusions: Patients with NAFLD are at heightened risk of extrahepatic outcomes. However, the certainty of evidence is only from very low to moderate. Further studies at low risk of bias are required to support the evidence and elucidate any causal associations.

PubMed Disclaimer

References

REFERENCES

    1. Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:60-78. https://doi.org/10.1038/s41575-021-00523-4
    1. Durand F, Pavesi M, Cheung R. Liver transplantation for non-alcoholic steatohepatitis in Europe: where do we stand? J Hepatol. 2019;71:240-2. https://doi.org/10.1016/j.jhep.2019.05.018
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73-84. https://doi.org/10.1002/hep.28431
    1. Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72:1605-16. https://doi.org/10.1002/hep.31173
    1. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123-33. https://doi.org/10.1002/hep.29466

Publication types

LinkOut - more resources